NEW YORK, April 17, 2018 - Arsenal Capital Partners (“Arsenal”), a leading private equity firm that invests in middle-market specialty industrials and healthcare business services companies, announced today an investment to purchase a majority interest in Fralock.
Founded in 1967, Fralock is a specialty materials company that designs, engineers, and manufactures high-performance components and subassemblies for world-class companies in the semiconductor equipment, life science, aerospace, and satellite industries.
Polymer Solutions Group (PSG), a leading manufacturer of specialty polymers and additives, today announced its plan to acquire the assets of Phoenix Chemical Company, Inc. The transaction is expected to close by the end of January. PSG is a portfolio company of Arsenal Capital Partners (“Arsenal”) and was established in June 2015.
Arsenal announced today that it has acquired Carolina Color Corporation as well as Breen Color Concentrates, LLC alongside the management teams of each company.
Arsenal announced today that it has signed a definitive agreement to sell Accella Performance Materials, a leading North American specialty polyurethane platform, to Carlisle Companies Incorporated for $670 million.
NEW YORK, September 18, 2017 - Arsenal Capital Partners (“Arsenal”), a leading New York-based private equity firm that invests in middle-market specialty industrials and healthcare companies, announced today the acquisition of Cyalume Technologies (“Cyalume”), a leading specialty chemicals provider to diversified end markets.
